Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Who We Play For is a U.S.-based nonprofit healthcare organization focused on preventing sudden cardiac death in young people through affordable, non-invasive electrocardiogram heart screening programs. The organization was founded in response to the death of student athlete Rafe Maccarone and works with schools, sports clubs, physicians, and communities to expand access to ECG screening, AED placement, and cardiac-awareness education. Its core service is operational heart-screening events interpreted by cardiology experts, rather than development of therapeutics. The group also partners with cardiac technology providers and promotes public-awareness initiatives intended to identify undiagnosed heart conditions before a catastrophic event occurs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Who We Play For.